nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisatracurium Besylate—Hypoxic-ischaemic encephalopathy—Aminophylline—chronic obstructive pulmonary disease	0.116	0.226	CcSEcCtD
Cisatracurium Besylate—Brain injury—Aminophylline—chronic obstructive pulmonary disease	0.0484	0.0937	CcSEcCtD
Cisatracurium Besylate—CHRND—Highly sodium permeable acetylcholine nicotinic receptors—CHRNA3—chronic obstructive pulmonary disease	0.0319	0.0659	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.0272	0.0562	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.0258	0.0534	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Presynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.0254	0.0525	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.0232	0.0478	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Acetylcholine Binding And Downstream Events—CHRNA5—chronic obstructive pulmonary disease	0.0225	0.0464	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.0222	0.0458	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.022	0.0455	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Presynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.0216	0.0446	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Highly calcium permeable nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.0211	0.0435	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Presynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.0207	0.0428	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Presynaptic nicotinic acetylcholine receptors—CHRNA5—chronic obstructive pulmonary disease	0.0205	0.0424	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Acetylcholine Binding And Downstream Events—CHRNA5—chronic obstructive pulmonary disease	0.0191	0.0395	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.0189	0.039	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Acetylcholine Binding And Downstream Events—CHRNA3—chronic obstructive pulmonary disease	0.0183	0.0378	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Acetylcholine Binding And Downstream Events—CHRNA5—chronic obstructive pulmonary disease	0.0181	0.0375	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Highly calcium permeable postsynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.0179	0.0371	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Presynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.0176	0.0364	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Presynaptic nicotinic acetylcholine receptors—CHRNA3—chronic obstructive pulmonary disease	0.0167	0.0346	CbGpPWpGaD
Cisatracurium Besylate—CHRNA1—Acetylcholine Binding And Downstream Events—CHRNA3—chronic obstructive pulmonary disease	0.0156	0.0322	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Acetylcholine Binding And Downstream Events—CHRNA3—chronic obstructive pulmonary disease	0.0148	0.0306	CbGpPWpGaD
Cisatracurium Besylate—Trauma—Formoterol—chronic obstructive pulmonary disease	0.0112	0.0217	CcSEcCtD
Cisatracurium Besylate—Trauma—Arformoterol—chronic obstructive pulmonary disease	0.0112	0.0217	CcSEcCtD
Cisatracurium Besylate—Trauma—Montelukast—chronic obstructive pulmonary disease	0.011	0.0213	CcSEcCtD
Cisatracurium Besylate—Trauma—Prednisolone—chronic obstructive pulmonary disease	0.00608	0.0118	CcSEcCtD
Cisatracurium Besylate—Anaphylactoid reaction—Aminophylline—chronic obstructive pulmonary disease	0.00526	0.0102	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Roflumilast—chronic obstructive pulmonary disease	0.00519	0.0101	CcSEcCtD
Cisatracurium Besylate—Wheezing—Montelukast—chronic obstructive pulmonary disease	0.00508	0.00984	CcSEcCtD
Cisatracurium Besylate—Wheezing—Salbutamol—chronic obstructive pulmonary disease	0.0049	0.00949	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00477	0.00925	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00476	0.00923	CcSEcCtD
Cisatracurium Besylate—Trauma—Prednisone—chronic obstructive pulmonary disease	0.00441	0.00855	CcSEcCtD
Cisatracurium Besylate—Injury—Arformoterol—chronic obstructive pulmonary disease	0.00422	0.00817	CcSEcCtD
Cisatracurium Besylate—Injury—Formoterol—chronic obstructive pulmonary disease	0.00422	0.00817	CcSEcCtD
Cisatracurium Besylate—Angioedema—Roflumilast—chronic obstructive pulmonary disease	0.0042	0.00815	CcSEcCtD
Cisatracurium Besylate—Injury—Montelukast—chronic obstructive pulmonary disease	0.00413	0.00801	CcSEcCtD
Cisatracurium Besylate—Myopathy—Prednisolone—chronic obstructive pulmonary disease	0.00412	0.00799	CcSEcCtD
Cisatracurium Besylate—Injury—Salbutamol—chronic obstructive pulmonary disease	0.00398	0.00772	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00389	0.00754	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00368	0.00713	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00365	0.00707	CcSEcCtD
Cisatracurium Besylate—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00356	0.00735	CbGpPWpGaD
Cisatracurium Besylate—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.0033	0.00639	CcSEcCtD
Cisatracurium Besylate—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.0033	0.00639	CcSEcCtD
Cisatracurium Besylate—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00327	0.00634	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Tiotropium—chronic obstructive pulmonary disease	0.00327	0.00633	CcSEcCtD
Cisatracurium Besylate—CHRNA1—ErbB2/ErbB3 signaling events—ERBB3—chronic obstructive pulmonary disease	0.00312	0.00645	CbGpPWpGaD
Cisatracurium Besylate—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.00311	0.00603	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00303	0.00625	CbGpPWpGaD
Cisatracurium Besylate—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.00302	0.00584	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Tiotropium—chronic obstructive pulmonary disease	0.003	0.00582	CcSEcCtD
Cisatracurium Besylate—Myopathy—Prednisone—chronic obstructive pulmonary disease	0.003	0.00581	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.003	0.0058	CcSEcCtD
Cisatracurium Besylate—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00298	0.00578	CcSEcCtD
Cisatracurium Besylate—CHRND—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.0029	0.00599	CbGpPWpGaD
Cisatracurium Besylate—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00287	0.00594	CbGpPWpGaD
Cisatracurium Besylate—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00277	0.00536	CcSEcCtD
Cisatracurium Besylate—CHRND—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00268	0.00553	CbGpPWpGaD
Cisatracurium Besylate—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00266	0.00515	CcSEcCtD
Cisatracurium Besylate—Angioedema—Tiotropium—chronic obstructive pulmonary disease	0.00264	0.00512	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Formoterol—chronic obstructive pulmonary disease	0.00264	0.00511	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Arformoterol—chronic obstructive pulmonary disease	0.00264	0.00511	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Montelukast—chronic obstructive pulmonary disease	0.00258	0.005	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.0025	0.00485	CcSEcCtD
Cisatracurium Besylate—Hypertension—Tiotropium—chronic obstructive pulmonary disease	0.0025	0.00484	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Salbutamol—chronic obstructive pulmonary disease	0.00249	0.00482	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00247	0.0051	CbGpPWpGaD
Cisatracurium Besylate—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00246	0.00476	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00245	0.00474	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Aminophylline—chronic obstructive pulmonary disease	0.00244	0.00474	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00242	0.00469	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.00242	0.00469	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00242	0.00468	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00242	0.00468	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.00237	0.0046	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00237	0.00459	CcSEcCtD
Cisatracurium Besylate—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00237	0.00459	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.00237	0.00458	CcSEcCtD
Cisatracurium Besylate—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.00235	0.00455	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00234	0.00484	CbGpPWpGaD
Cisatracurium Besylate—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00234	0.00453	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00232	0.00449	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Tiotropium—chronic obstructive pulmonary disease	0.0023	0.00447	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.0023	0.00445	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00229	0.00444	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00229	0.00443	CcSEcCtD
Cisatracurium Besylate—Injury—Prednisolone—chronic obstructive pulmonary disease	0.00228	0.00443	CcSEcCtD
Cisatracurium Besylate—Mediastinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00228	0.00442	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00227	0.0047	CbGpPWpGaD
Cisatracurium Besylate—CHRND—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00218	0.00451	CbGpPWpGaD
Cisatracurium Besylate—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.00217	0.0042	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00216	0.00447	CbGpPWpGaD
Cisatracurium Besylate—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.00213	0.00413	CcSEcCtD
Cisatracurium Besylate—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.00213	0.00413	CcSEcCtD
Cisatracurium Besylate—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.00209	0.00405	CcSEcCtD
Cisatracurium Besylate—CHRND—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00205	0.00424	CbGpPWpGaD
Cisatracurium Besylate—Hypertension—Arformoterol—chronic obstructive pulmonary disease	0.00202	0.00391	CcSEcCtD
Cisatracurium Besylate—Hypertension—Formoterol—chronic obstructive pulmonary disease	0.00202	0.00391	CcSEcCtD
Cisatracurium Besylate—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.00201	0.0039	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Prednisolone—chronic obstructive pulmonary disease	0.002	0.00387	CcSEcCtD
Cisatracurium Besylate—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00199	0.00385	CcSEcCtD
Cisatracurium Besylate—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00198	0.00384	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00197	0.00383	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00197	0.00383	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00193	0.00375	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00191	0.00369	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00191	0.00369	CcSEcCtD
Cisatracurium Besylate—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.0019	0.00369	CcSEcCtD
Cisatracurium Besylate—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00188	0.00363	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00187	0.00362	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00187	0.00362	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00187	0.00362	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00186	0.0036	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00186	0.0036	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00185	0.00383	CbGpPWpGaD
Cisatracurium Besylate—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00185	0.00359	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00185	0.00359	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00185	0.00359	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00184	0.00357	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00183	0.00355	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00181	0.00351	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.0018	0.00349	CcSEcCtD
Cisatracurium Besylate—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00178	0.00345	CcSEcCtD
Cisatracurium Besylate—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00178	0.00345	CcSEcCtD
Cisatracurium Besylate—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00177	0.00343	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00176	0.00342	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00176	0.00364	CbGpPWpGaD
Cisatracurium Besylate—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00176	0.0034	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00175	0.00339	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00174	0.0036	CbGpPWpGaD
Cisatracurium Besylate—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00174	0.00337	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.0017	0.00329	CcSEcCtD
Cisatracurium Besylate—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.0017	0.00329	CcSEcCtD
Cisatracurium Besylate—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00168	0.00326	CcSEcCtD
Cisatracurium Besylate—CHRND—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00167	0.00345	CbGpPWpGaD
Cisatracurium Besylate—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00167	0.00324	CcSEcCtD
Cisatracurium Besylate—Injury—Prednisone—chronic obstructive pulmonary disease	0.00166	0.00322	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00166	0.00342	CbGpPWpGaD
Cisatracurium Besylate—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.0016	0.00311	CcSEcCtD
Cisatracurium Besylate—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00158	0.00306	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00158	0.00306	CcSEcCtD
Cisatracurium Besylate—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00151	0.00293	CcSEcCtD
Cisatracurium Besylate—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00151	0.00293	CcSEcCtD
Cisatracurium Besylate—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00149	0.00288	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00149	0.00288	CcSEcCtD
Cisatracurium Besylate—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00148	0.00287	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.00148	0.00287	CcSEcCtD
Cisatracurium Besylate—Cardiac arrest—Prednisone—chronic obstructive pulmonary disease	0.00145	0.00281	CcSEcCtD
Cisatracurium Besylate—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00143	0.00277	CcSEcCtD
Cisatracurium Besylate—CHRNA1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00142	0.00294	CbGpPWpGaD
Cisatracurium Besylate—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.0014	0.00272	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.0014	0.00272	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00138	0.00266	CcSEcCtD
Cisatracurium Besylate—CHRNA2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00135	0.00279	CbGpPWpGaD
Cisatracurium Besylate—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00135	0.00261	CcSEcCtD
Cisatracurium Besylate—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00135	0.00261	CcSEcCtD
Cisatracurium Besylate—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.00135	0.00261	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00133	0.00257	CcSEcCtD
Cisatracurium Besylate—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00132	0.00256	CcSEcCtD
Cisatracurium Besylate—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00247	CcSEcCtD
Cisatracurium Besylate—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00126	0.00245	CcSEcCtD
Cisatracurium Besylate—Rash—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00233	CcSEcCtD
Cisatracurium Besylate—Rash—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00233	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00233	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00233	CcSEcCtD
Cisatracurium Besylate—Rash—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00228	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00228	CcSEcCtD
Cisatracurium Besylate—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.00116	0.00224	CcSEcCtD
Cisatracurium Besylate—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.0022	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.0022	CcSEcCtD
Cisatracurium Besylate—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.0011	0.00212	CcSEcCtD
Cisatracurium Besylate—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.00109	0.00212	CcSEcCtD
Cisatracurium Besylate—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00208	CcSEcCtD
Cisatracurium Besylate—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.00104	0.00201	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.00103	0.002	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00101	0.00195	CcSEcCtD
Cisatracurium Besylate—Flushing—Prednisone—chronic obstructive pulmonary disease	0.00098	0.0019	CcSEcCtD
Cisatracurium Besylate—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000958	0.00186	CcSEcCtD
Cisatracurium Besylate—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000953	0.00185	CcSEcCtD
Cisatracurium Besylate—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000919	0.00178	CcSEcCtD
Cisatracurium Besylate—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.00084	0.00163	CcSEcCtD
Cisatracurium Besylate—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.00082	0.00159	CcSEcCtD
Cisatracurium Besylate—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000796	0.00154	CcSEcCtD
Cisatracurium Besylate—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000793	0.00154	CcSEcCtD
Cisatracurium Besylate—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000777	0.00151	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.00076	0.00147	CcSEcCtD
Cisatracurium Besylate—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.00075	0.00145	CcSEcCtD
Cisatracurium Besylate—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000735	0.00143	CcSEcCtD
Cisatracurium Besylate—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000732	0.00142	CcSEcCtD
Cisatracurium Besylate—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000728	0.00141	CcSEcCtD
Cisatracurium Besylate—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000651	0.00126	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.00065	0.00126	CcSEcCtD
Cisatracurium Besylate—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000596	0.00115	CcSEcCtD
Cisatracurium Besylate—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000553	0.00107	CcSEcCtD
Cisatracurium Besylate—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000531	0.00103	CcSEcCtD
Cisatracurium Besylate—Rash—Prednisone—chronic obstructive pulmonary disease	0.000473	0.000916	CcSEcCtD
Cisatracurium Besylate—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000472	0.000915	CcSEcCtD
